Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Effects of Different Dosing Schedules of Irinotecan Hydrochloride, Calcium Folinate, and Fluorouracil in Patients with Metastatic Colorectal Cancer

    Not yet recruiting

    2 1 1 1
    Hungary
  • Study on Vinorelbine for Patients with Metastatic Colorectal Cancer

    Not yet recruiting

    2 1 1 1
    Italy
  • Study on the Safety and Effectiveness of Nivolumab and Ipilimumab for Patients with Metastatic Colorectal Cancer with dMMR or MSI

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    France
  • Study of Irinotecan with FOLFOX and Bevacizumab for Patients with Unresectable Colorectal Cancer Metastases

    Not yet recruiting

    2 1 1 1
    The Netherlands
  • Study on the Effectiveness of Floxuridine in Patients with Resectable Colorectal Liver Metastases and Low Clinical Risk Score

    Not yet recruiting

    3 1 1 1
    The Netherlands
  • Study of LB-100 and Azenosertib for Patients with Metastatic Colorectal Cancer

    Not yet recruiting

    1 1 1
    Investigated diseases:
    The Netherlands
  • Study Comparing Panitumumab and Regorafenib Sequence for Patients with Metastatic Colorectal Cancer Resistant to Previous Treatments

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Italy
  • Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Portugal Spain
  • A Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France Germany Italy The Netherlands Poland Spain
  • Study of Pembrolizumab and Temozolomide for Patients with Metastatic Colorectal Cancer Who Have Not Responded to Standard Treatments

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Italy